Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cyclooxygenase Inhibitors [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
ASPIRIN 92,524 13,029 14.1% 53,089 6,177 66.1 yrs 47.2%
IBUPROFEN 87,008 6,705 7.7% 29,386 5,875 44.0 yrs 60.9%
DICLOFENAC 86,819 6,378 7.3% 16,398 6,830 55.4 yrs 74.8%
NAPROXEN 52,751 5,127 9.7% 12,849 4,592 55.0 yrs 71.5%
CELECOXIB 31,698 4,470 14.1% 9,081 3,841 56.6 yrs 79.6%
MELOXICAM 8,661 1,042 12.0% 2,502 555 57.6 yrs 72.7%
KETOROLAC TROMETHAMINE 6,160 235 3.8% 1,332 261 49.7 yrs 62.0%
KETOPROFEN 5,550 393 7.1% 2,947 654 47.9 yrs 61.9%
INDOMETHACIN 4,831 664 13.7% 1,146 312 45.8 yrs 79.1%
NEPAFENAC 1,761 5 0.3% 46 2 65.7 yrs 60.2%

Head-to-Head Comparisons

ASPIRIN vs IBUPROFEN ASPIRIN vs DICLOFENAC ASPIRIN vs NAPROXEN ASPIRIN vs CELECOXIB IBUPROFEN vs DICLOFENAC IBUPROFEN vs NAPROXEN IBUPROFEN vs CELECOXIB DICLOFENAC vs NAPROXEN DICLOFENAC vs CELECOXIB NAPROXEN vs CELECOXIB
← Back to Cyclooxygenase Inhibitors [MoA] Class side effects →